4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-25-020241
President & COO sold 100,000 shares at $10.95 ($1,095,000)
- President & COO gave up 39,148 shares (to pay taxes)
- President & COO acquired 100,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venker Eric President & COO | 2025-05-20 | Shares withheld for taxes 10b5-1 | −39,148 | $11.04 | $432,194 | 1,077,197 | D: show line 1 in the form |
| Venker Eric President & COO | 2025-05-20 | Option exercise 10b5-1 | +100,000 | $3.85 | $385,000 | 1,177,197 | D: show line 2 in the form |
| Venker Eric President & COO | 2025-05-20 | Sale 10b5-1 | −100,000 | $10.95 | $1,095,000 | 1,077,197 | D: show line 3 in the form |
| Open-market sales · 100,000 sh · avg $10.95 · $1,095,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Venker Eric President & COO | 2025-05-20 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −100,000 | 9,723,923 | D: show line 4 in the form |
Loading xslF345X05/form4.xml…